← Leaderboards
Daniel R Prows
Children'S Hospital Med Ctr (Cincinnati)
$5,118,958
Attributed
$5,333,458
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $633.8K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,333,458 · 5
By mechanism
R01$3,046,243 · 1
P01$1,042,855 · 1
R21$866,250 · 2
R56$378,110 · 1
Top collaborators
- Nives Zimmermann2 shared
Most similar at Children'S Hospital Med Ctr (Cincinnati)
Same institution · by research overlap
- Stephan W. Glasser$4,593,350
Others in their field
Top investigators on “Backcrossings”
- Allan Balmain · University Of California San Francisco$17,817,658
- Ronald Walter · Texas State University-San Marcos$8,411,044
- Arlene H Sharpe · Harvard Medical School$5,844,746
- Norman R Klinman · Scripps Research Institute$5,425,645
- Gregory M Barton · University Of California Berkeley$5,023,552
- Shu Man Fu · University Of Virginia Charlottesville$4,787,791
Research focus
BackcrossingsComplexGenesAffectCandidate Disease GeneMouse ModelGeneticQuantitative Trait LociTraitLinkMolecularCessation Of LifePathologicAllelesLung InjuryMaleRecombinantsSegregationPenetranceMortality Vital StatisticsGenomePredispositionFundingNames
Grant awards (18)
Reconstituting the oligogenic trait 'Eosinophilic myocarditis to heart disease' in Collaborative Cross lines to understand its genetic architecture$198,750
R21 · FY2021 · AI · contact PI
Reconstituting the oligogenic trait 'Eosinophilic myocarditis to heart disease' in Collaborative Cross lines to understand its genetic architecture$238,500
R21 · FY2020 · AI · contact PI
A Novel Mouse Model of Eosinophilic Vasculitis with Cardiac Complications$195,000
R21 · FY2018 · HL · contact PI
A Novel Mouse Model of Eosinophilic Vasculitis with Cardiac Complications$234,000
R21 · FY2017 · HL · contact PI
Genetic Analysis of Hyperoxia Induced Acute Lung Injury$386,322
R01 · FY2012 · HL · contact PI
Genetic Analysis of Hyperoxia Induced Acute Lung Injury$386,322
R01 · FY2011 · HL · contact PI
Genetic Analysis of Hyperoxia Induced Acute Lung Injury$390,209
R01 · FY2010 · HL · contact PI
Genetic Analysis of Hyperoxia Induced Acute Lung Injury$424,015
R01 · FY2009 · HL · contact PI
Genetic Analysis of Hyperoxia Induced Acute Lung Injury$378,110
R56 · FY2008 · HL · contact PI
Modifier Genes of SP-C Induced ILD$255,681
P01 · FY2008 · HL · contact PI
Genetic analysis of hyperoxia-induced acute lung injury$353,197
R01 · FY2007 · HL · contact PI
Modifier Genes of SP-C Induced ILD$253,296
P01 · FY2007 · HL · contact PI
Genetic analysis of hyperoxia-induced acute lung injury$363,746
R01 · FY2006 · HL · contact PI
Modifier Genes of SP-C Induced ILD$173,634
P01 · FY2006 · HL · contact PI
Genetic analysis of hyperoxia-induced acute lung injury$372,500
R01 · FY2005 · HL
Modifier Genes of SP-C Induced ILD$168,577
P01 · FY2005 · HL
Genetic analysis of hyperoxia-induced acute lung injury$369,932
R01 · FY2004 · HL
Modifier Genes of SP-C Induced ILD$191,667
P01 · FY2004 · HL